Relationship between the Pharmacokinetics of Irinotecan and Diarrhea during Combination Chemotherapy with Cisplatin

Two phase I trials of irinotecan (CPT‐11) in combination with cisplatin were conducted. In both cases, the dose‐limiting toxicities were leukopenia and/or diarrhea. During these trials the pharmacokinetics of CPT‐11 and its active metabolite, 7‐ethyl‐10‐hydroxycamptothecin (SN‐38), were investigated...

Descripción completa

Detalles Bibliográficos
Autores principales: Kudoh, Shinzoh, Fukuoka, Masahiro, Masuda, Noriyuki, Yoshikawa, Atsuko, Kusunoki, Yoko, Matsui, Kaoru, Negoro, Shun‐ichi, Takifuji, Nobuhide, Nakagawa, Kazuhiko, Hirashima, Tomonori, Yana, Takashi, Takada, Minoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1995
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920836/
https://www.ncbi.nlm.nih.gov/pubmed/7775263
http://dx.doi.org/10.1111/j.1349-7006.1995.tb03071.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920836/
https://www.ncbi.nlm.nih.gov/pubmed/7775263
http://dx.doi.org/10.1111/j.1349-7006.1995.tb03071.x

Ejemplares similares